Medicare Advantage just shifted again — and 2027 is already reshaping your 2026 strategy.

If you think the 2027 Advance Notice is just another routine CMS update… think again.

Inside this guide, we break down:

📉 A projected $1.2M funding reduction per 10,000 MA lives
📊 $2.3M impact tied to coefficient shifts in the top 10 chronic conditions
⚠️ 65 HCCs with decreased weights — including diabetes, COPD, CKD, heart failure, and depression
🚫 Elimination of unlinked chart review records (CRRs) for RAF scoring
📞 Exclusion of audio-only telehealth diagnoses
🔍 Rising OIG and RADV scrutiny targeting high-weight acute conditions like sepsis and cancers

Margins are tightening. Regulatory pressure is increasing. And CMS adopts more than 90% of what it proposes. So we expect most of this to be final.

If you lead in risk adjustment, CDI, coding, finance, or population health, you need to understand:
• Where the money is shifting
• Where audit risk is intensifying
• How to protect reimbursement without increasing compliance exposure
• What to prioritize right now — before the Final Rate Announcement drops

This is one of the most important MA reads of the year.

Download CMS 2027 Advance Notice: A Continuously Shifting Landscape for Medicare Advantage.

Don’t wait until 2027 payments hit to realize what changed.